https://orcid.org/0000-0002-4173-6490
Citations (27)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Abdulrhman Al Rowily, Zahraa Jalal & Vibhu Paudyal. (2023) Contributory factors and patient harm including deaths associated direct acting oral anticoagulants (DOACs) medication incidents: evaluation of real world data reported to the National Reporting and Learning System. Expert Opinion on Drug Safety 22:11, pages 1113-1125.
Read now
Read now
Raymond Li, Kate Curtis, Syed Tabish Zaidi, Connie Van & Ronald Castelino. (2022) A new paradigm in adverse drug reaction reporting: consolidating the evidence for an intervention to improve reporting. Expert Opinion on Drug Safety 21:9, pages 1193-1204.
Read now
Read now
Milica Paut Kusturica, Ana Tomas, Aleksandar Rašković, Slobodan Gigov, Veljko Crnobrnja, Marija Jevtić & Nebojša Stilinović. (2022) Community pharmacists’ challenges regarding adverse drug reaction reporting: a cross-sectional study. Current Medical Research and Opinion 38:7, pages 1229-1236.
Read now
Read now
Articles from other publishers (24)
Catarina Costa, Patricia Abeijon, Daniela A. Rodrigues, Adolfo Figueiras, Maria Teresa Herdeiro & Carla Torre. (2023) Factors associated with underreporting of adverse drug reactions by patients: a systematic review. International Journal of Clinical Pharmacy 45:6, pages 1349-1358.
Crossref
Crossref
Prat Sébastien, Dalbin Jacques, Plotton Catherine & Gocko Xavier. (2023) Diagnosis and treatment of “chronic Lyme”: primum non nocere. BMC Infectious Diseases 23:1.
Crossref
Crossref
Kathleen Bennett, Caitriona Cahir & Jan Sorensen. (2023) Costs associated with adverse drug reactions in an older population admitted to hospital: a prospective cohort study. European Journal of Clinical Pharmacology 79:10, pages 1417-1424.
Crossref
Crossref
Gaetano La Mantia, Fortunato Buttacavoli, Vera Panzarella, Giuseppe Colella, Annalisa Capuano, Liberata Sportiello, Gaspare Parrinello, Ilaria Morreale, Giacomo Oteri, Giuseppe Bellavia, Vittorio Fusco, Rodolfo Mauceri, Martina Coppini, Monica Bazzano, Giuseppe Seminara, Olga Di Fede & Giuseppina Campisi. (2023) Oro-Dental Pharmacovigilance in the Digital Age: Promoting Knowledge, Awareness, and Practice in Italy through a Smart Combined System—A Conference at the 30th National Congress of the Italian College of University Professors of Dental Disciplines. Oral 3:3, pages 411-419.
Crossref
Crossref
Olga Menang, Andrea Kuemmerle, Karen Maigetter & Christian Burri. (2023) Strategies and interventions to strengthen pharmacovigilance systems in low-income and middle-income countries: a scoping review. BMJ Open 13:9, pages e071079.
Crossref
Crossref
Philip Alexander Routledge & Robert Bracchi. (2023) Improving the spontaneous reporting of suspected adverse drug reactions: An overview of systematic reviews. British Journal of Clinical Pharmacology 89:8, pages 2377-2385.
Crossref
Crossref
Laila Shafei, Lina Mekki, Esraa Maklad, Turfa Alhathal, Rawan Ghanem, Rama Almalouf, Derek Stewart & Zachariah Nazar. (2023) Factors that influence patient and public adverse drug reaction reporting: a systematic review using the theoretical domains framework. International Journal of Clinical Pharmacy 45:4, pages 801-813.
Crossref
Crossref
Joel Fossouo Tagne, Reginald Amin Yakob, Rachael Mcdonald & Nilmini Wickramasinghe. (2023) A Web-Based Tool to Report Adverse Drug Reactions by Community Pharmacist in Australia: Usability Testing Study (Preprint). JMIR Formative Research.
Crossref
Crossref
Joel Fossouo Tagne, Reginald Amin Yakob, Rachael Mcdonald & Nilmini Wickramasinghe. (2023) Linking Activity Theory Within User-Centered Design: Novel Framework to Inform Design and Evaluation of Adverse Drug Reaction Reporting Systems in Pharmacy. JMIR Human Factors 10, pages e43529.
Crossref
Crossref
Joel Fossouo Tagne, Reginald Amin Yakob, Thu Ha Dang, Rachael Mcdonald & Nilmini Wickramasinghe. (2023) Reporting, Monitoring, and Handling of Adverse Drug Reactions in Australia: Scoping Review. JMIR Public Health and Surveillance 9, pages e40080.
Crossref
Crossref
Vanessa S. G. Teófilo, Paulo R. A. Pinho, Gonçalo J. Cordeiro, Nuno A. F. Saldanha, Pedro M. M. Matos, Rui A. M. Ribeiro, Salomé M. Moreira, Mariana S. F Miller, Andreia R. M. Dias, Marta F. R. Couto & Pedro M. P. N. S. Norton. (2023) Spontaneous reporting of adverse reactions associated with the COVID-19 vaccine in health care professionals: A descriptive observational study conducted in a Portuguese hospital. Porto Biomedical Journal 8:3.
Crossref
Crossref
Jingchao Yan, Xiaomei Xiong, Jianwen Shen & Taomin Huang. (2022) Adverse drug reaction reporting quality among different health professionals and the contribution of clinical pharmacists: A pilot study. Journal of Clinical Pharmacy and Therapeutics 47:11, pages 1768-1774.
Crossref
Crossref
Joel Fossouo Tagne, Reginald Amin Yakob, Rachael Mcdonald & Nilmini Wickramasinghe. (2022) Barriers and Facilitators Influencing Real-time and Digital-Based Reporting of Adverse Drug Reactions by Community Pharmacists: Qualitative Study Using the Task-Technology Fit Framework. Interactive Journal of Medical Research 11:2, pages e40597.
Crossref
Crossref
Renly Lim, Christopher Thornton, Jan Stanek, Lisa Kalisch Ellett & Myra Thiessen. (2022) Development of a Web-Based System to Report Medication-Related Adverse Effects: Design and Usability Study. JMIR Formative Research 6:10, pages e37605.
Crossref
Crossref
Anne T. M. Dittrich, Nori J. L. Smeets, Emma F. M. de Jong, Juliët L. Kämink, Yvet Kroeze, Jos M. Th. Draaisma, Eugène P. van Puijenbroek & D. Maroeska W. M. te Loo. (2022) Quality of Active versus Spontaneous Reporting of Adverse Drug Reactions in Pediatric Patients: Relevance for Pharmacovigilance and Knowledge in Pediatric Medical Care. Pharmaceuticals 15:9, pages 1148.
Crossref
Crossref
Paul N. Deslandes, Robert Bracchi, Karen Jones, Kath E. Haines, Emma Carey, Alana Adams, Jenna Walker, Alison Thomas & Philip A. Routledge. (2022) Changes in suspected adverse drug reaction reporting via the yellow card scheme in Wales following the introduction of a National Reporting Indicator. British Journal of Clinical Pharmacology 88:8, pages 3829-3836.
Crossref
Crossref
Bipin Chaurasia, Vishal Chavda, Bingwei Lu, Kanwaljeet Garg & Nicola Montemurro. (2022) Cognitive deficits and memory impairments after COVID-19 (Covishield) vaccination. Brain, Behavior, & Immunity - Health 22, pages 100463.
Crossref
Crossref
Raymond Li, Kate Curtis, Connie Van, Syed Tabish Razi Zaidi, Chin Yen Yeo, Christina Arun Kali, Mithila Zaheen, Grace Therese Moujalli & Ronald Castelino. (2022) Why hospital-based healthcare professionals do not report adverse drug reactions: a mixed methods study using the Theoretical Domains Framework. European Journal of Clinical Pharmacology 78:7, pages 1165-1175.
Crossref
Crossref
P. Ravi Shankar. 2020. Encyclopedia of Evidence in Pharmaceutical Public Health and Health Services Research in Pharmacy. Encyclopedia of Evidence in Pharmaceutical Public Health and Health Services Research in Pharmacy
1
29
.
Hari Pretha Nair Raghvan & Omotayo Fatokun. (2021) Factors associated with the intention of community pharmacists to report adverse drug reactions to regulatory authority in Malaysia: application of the theory of planned behaviour. International Journal of Pharmacy Practice 29:5, pages 435-442.
Crossref
Crossref
Sunil Shrestha, Januka Khatri, Sujyoti Shakya, Krisha Danekhu, Asmita Priyadarshini Khatiwada, Ranjit Sah, Bhuvan KC, Vibhu Paudyal, Saval Khanal & Alfonso J. Rodriguez-Morales. (2021) Adverse events related to COVID-19 vaccines: the need to strengthen pharmacovigilance monitoring systems. Drugs & Therapy Perspectives 37:8, pages 376-382.
Crossref
Crossref
Malahat Khalili, Bita Mesgarpour, Hamid Sharifi, Asieh Golozar & Ali Akbar Haghdoost. (2021) Estimation of adverse drug reaction reporting in Iran: Correction for underreporting. Pharmacoepidemiology and Drug Safety 30:8, pages 1101-1114.
Crossref
Crossref
Madison Milne-Ives, Ching Lam, Najib Rehman, Raja Sharif & Edward Meinert. (2021) Distributed Ledger Infrastructure to Verify Adverse Event Reporting (DeLIVER): Proposal for a Proof-of-Concept Study. JMIR Research Protocols 10:6, pages e28616.
Crossref
Crossref
Nuria Cantero-López, Víctor M. González-Chordá, María Jesús Valero-Chillerón, Desirée Mena-Tudela, Laura Andreu-Pejó, Rafael Vila-Candel & Águeda Cervera-Gasch. (2021) Attitudes of Undergraduate Nursing Students towards Patient Safety: A Quasi-Experimental Study. International Journal of Environmental Research and Public Health 18:4, pages 1429.
Crossref
Crossref